Encompass Health Corp (EHC) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 19, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
23
Open-market buys
0
Open-market sells
6

Counts cover the 23 most recent Form 4 filings Tradune holds for EHC (filed Jul 16 – Oct 19, 2026); the score below covers only the trailing 90 days (0 buys, 6 sells). No completed check of EHC's Form 4 list on SEC EDGAR is on record yet; the latest EHC filing Tradune holds was filed Oct 19, 2026. This is not guaranteed to be the complete record — see EHC's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 14 filings Tradune holds for EHC filed Aug 11 – Oct 19, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

6 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
6 sales· 210,992 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Mark J. TarrPresident & CEO 0 2 — 173,148 −$21,724,095
John Patrick DarbyEVP, Gen Counsel & Secretary 0 2 — 13,764 −$1,709,966
Douglas E. ColtharpEVP & Chief Financial Officer 0 1 — 18,869 −$2,365,795
Andrew L. PriceChief Accounting Officer 0 1 — 5,211 −$630,166

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 6 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at EHC

No open-market insider purchases (Form 4 code P) were reported for EHC between Jul 16, 2026 and Oct 19, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Edward M. Christie III Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 221 $126.63 9,577 +2.4% Oct 19, 2026
Grant / award 11 — 9,356 +0.1% Oct 15, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Christopher R. Reidy Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 284 $126.89 18,081 +1.6% Oct 19, 2026
Grant / award 20 — 17,797 +0.1% Oct 15, 2026
Greg D. Carmichael Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 28 — 20,377 +0.1% Oct 15, 2026
Terrance Williams Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 28 — 16,887 +0.2% Oct 15, 2026
Nancy M. Schlichting Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 38 — 23,010 +0.2% Oct 15, 2026
Joan E. Herman Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 81 — 49,724 +0.2% Oct 15, 2026
Cain A. Hayes Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 4 — 2,100 +0.2% Oct 15, 2026
Kevin J. O'Connor Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 18 — 11,600 +0.2% Oct 15, 2026
Leslye G. Katz Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 81 — 49,724 +0.2% Oct 15, 2026
Andrew L. Price Chief Accounting Officer · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 5,211 $120.93 69,483 −7.0% Aug 31, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

John Patrick Darby EVP, Gen Counsel & Secretary · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 4,858 $35.06 79,899 +6.5% Aug 31, 2026
Open-market sale 10b5-1 box not checked 4,858 $121.09 75,041 −6.1% Aug 31, 2026
Option exercise Non-qualified Stock Option (Right to Buy) 4,858 — — — Aug 31, 2026
Douglas E. Coltharp EVP & Chief Financial Officer · filed Aug 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 18,869 $125.38 50,508 −27% Aug 10, 2026
Mark J. Tarr President & CEO · filed Aug 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 171,569 $125.46 269,393 −39% Aug 10, 2026
Open-market sale 10b5-1 box not checked 1,579 $126.06 267,814 −0.6% Aug 10, 2026
John Patrick Darby EVP, Gen Counsel & Secretary · filed Aug 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 8,906 $125.95 75,041 −11% Aug 10, 2026
Christopher R. Reidy Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 319 $112.40 17,777 +1.8% Jul 16, 2026
Grant / award 21 — 17,458 +0.1% Jul 15, 2026
Edward M. Christie III Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 248 $112.43 9,345 +2.7% Jul 16, 2026
Grant / award 11 — 9,097 +0.1% Jul 15, 2026
Terrance Williams Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 29 — 16,859 +0.2% Jul 15, 2026
Nancy M. Schlichting Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 40 — 22,972 +0.2% Jul 15, 2026
Kevin J. O'Connor Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 19 — 11,582 +0.2% Jul 15, 2026
Leslye G. Katz Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 85 — 49,643 +0.2% Jul 15, 2026
Joan E. Herman Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 85 — 49,643 +0.2% Jul 15, 2026
Cain A. Hayes Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 4 — 2,096 +0.2% Jul 15, 2026
Greg D. Carmichael Director · filed Jul 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 29 — 20,349 +0.1% Jul 15, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to EHC's (Oct 19, 2026).

Frequently asked about EHC insider activity

How many insiders bought EHC stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of EHC shares were reported by Encompass Health Corp insiders between Jul 16, 2026 and Oct 19, 2026. The 23 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for EHC?

The most recent Form 4 on this page was filed by Leslye G. Katz (Director) on Oct 19, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market EHC insider sale shown?

The largest open-market sale among the filings shown was 171,569 EHC shares at $125.46 (about $21,525,047) by Mark J. Tarr (President & CEO) on Aug 10, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for EHC — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track EHC insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.